CXCR2 and cancer: In addition, the infiltration of myeloid‐derived suppressor cells (MDSCs) is one of the key factors to protect tumors from the immune system and immunotherapy.[16] It was also increased by the upregulation of the chemokine CXCL5 in cancer cells, which is a well‐known ligand for CXCR2 on MDSCs.